The purpose of this contract was to further develop the work on gender and drugs at the European Monitoring Centre on Drugs and Drug Addiction (EMCDDA), with the specific objectives to: map and assess EMCDDA data and information on gender and drugs and identify existing gaps; identifying evidence-based gender sensitive interventions in the drug field and map gender sensitive interventions available in the European countries; prepare answers to key questions in the area of drugs and gender.
Period
1 Dec 2020 → 11 Dec 2021
Work for
European Monitoring Centre for Drugs and Drug Addiction, Portugal
